New hope for Kids' cystic fibrosis sinus problems
NCT ID NCT05581056
Summary
This study looked at whether CFTR modulator drugs, which are known to help lung function in cystic fibrosis, also improve sinus symptoms and quality of life in children aged 6 to 11. Researchers followed 27 children for a year, using a questionnaire to track changes in their sinus-related quality of life. The goal was to see if these treatments, already approved for older patients, provide benefits beyond just lung health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Femme Mère Enfant
Bron, Rhone, 69500, France
Conditions
Explore the condition pages connected to this study.